Establishment of the Intestinal Flora Transplantation Clinical Research Foundation
On Sunday, November 19, 2017, the Intestinal Flora Transplant Clinical Research Foundation was established.
The purpose of this research group, led by clinicians, is to establish a new treatment called “intestinal flora transplantation (fecal microorganism transplantation)” and to conduct activities to contribute to people’s health through research and development and clinical studies of intestinal flora transplantation.
The establishment ceremony was held at the “New Osaka Hotel” in Shin-Osaka. After the general meeting by the founding members, a study session and a reception were held, and despite being the first time, 30 people from all over Japan attended. We would like to take this opportunity to express our sincere appreciation.
Our study group will conduct activities to contribute to people’s health through research and development of intestinal flora transplantation and clinical studies.
The research and development department is located in the “Laboratory of Intestinal Bacteria (Symbiosis LLC)will be carrying out research and development. (The clinic has been conducting medical treatment and research as “Makoto Clinic,” but the research institute will be set up as an independent organization in conjunction with the launch of the research group.)
In the Clinical Research Division, specialists (“specialists”) will be appointed for each case, such as ulcerative colitis, Crohn’s disease, diabetes mellitus type II, psychiatric diseases, and immunological diseases. Partner Medical InstitutionsThe clinical research will be carried out by the “Japan Clinical Research Institute” (JCI).
Part 1: General Meeting
As the first part of the meeting, a general meeting was held by the founding members (directors, trustees, auditors, and the secretariat).
Part 2: Study Session (Panel Discussion)
Dr. Masayuki Asoholm (Life Clinic Tateshina: Nagano, Japan) started the study session.
Dr. Noriaki Man (Yorozu Clinic: Tottori, Japan)
Dr. Masahiko Shirotani (Luke’s Ashiya Clinic: Hyogo, Japan)
Mr. Makoto Shimizu (Symbiosis LLC)
Dr. Zen Tanaka (Tanaka Clinic: Osaka, Japan)
Everyone listened attentively.
Part 3: Social gathering
Toast by Mr. Goro Tsukamoto, Auditor.
Cheers! Congratulations!
We received a piece with a beaming smile. We have high expectations for the future of the study group.
The entire meeting was conducted in a friendly atmosphere.
The Intestinal Flora Transplantation Clinical Study Group will continue to devote itself to the work we have pledged to you at this founding meeting. We look forward to your continued support. その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

November 16, 2026
10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]
The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026
Survey Summary from the 10th Annual Academic Conference
The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024
〈Clinical Trial〉Completion Report
We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]